Alnylam Pharmaceuticals
Yuanfeng Wu is a Principal Scientist in Bioanalytical Sciences at Alnylam Pharmaceuticals, with a notable career trajectory that includes positions such as Senior Scientist at the same company and Senior Bioanalytical Lead Scientist at Pyxant Labs. In these roles, Yuanfeng has led and managed bioanalytical work to support both non-clinical and clinical studies, focusing on pharmacokinetics and toxicokinetics assays for small molecules and oligonucleotides across various matrices. Previous experience includes significant contributions at Covance, where Yuanfeng served as a Senior Bioanalytical Lead Scientist and Study Director in Toxicology, as well as a Visiting Scientist role at the FDA. Yuanfeng’s academic background includes a Ph.D. in Pharmacology and Toxicology from the University of Chinese Academy of Sciences and a Bachelor's degree in Biology from Fudan University.
This person is not in the org chart
Alnylam Pharmaceuticals
29 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.